Treefrog Therapeutics
French biotechnology company
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Treefrog Therapeutics is a French biotechnology company.
Recent events
TreeFrog Therapeutics appoints Frederic Desdouits as CEO[4]
Reported:
TreeFrog Therapeutics announced that independent board member Frederic Desdouits had been appointed chief executive officer in conjunction with the Series B financing.
TreeFrog Therapeutics closes $75 million Series B financing[4]
Reported:
TreeFrog Therapeutics announced that it had closed a $75 million (€64 million) Series B financing round, bringing total funding to date to $83 million (€70 million). The company said the funding would support deployment of its C-Stem technology for clinical-grade manufacturing, development of its cell-therapy pipeline, and the planned opening of technology hubs in Boston and Kobe.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/treefrog-therapeutics · Editorial policy · How profiles are compiled